Tokyo, Japan, July 6, 2017 --- Teijin Limited announced today that a practical demonstration of a medical-device management solution based on the company’s Recopick radio-frequency identification device (RFID) information-management system raised nursing efficiency, reduced stocking costs and improved device-maintenance management. The solution was trialed at St. Luke's International Hospital in Tokyo in the fiscal year ending in March 2016.
The demonstration proved that Recopick is a highly effective system for managing medical devices at hospitals. The system, by instantly identifying stocking levels in each ward, enabled St. Luke’s nurses to reduce their visits to the hospital’s clinical engineering room by around 55%. The frequency has been reduced down around 15% by expanding variations of medical device being managed by Recopick. As a result, nurses could reduce stock-related work and in turn spend more time caring for patients.
Also, by monitoring device operating hours per item or per day, Recopick enabled St. Luke’s to accurately forecast stocking needs and thereby reduce unnecessary stock worth JPY 19 million. In addition, information collected with Recopick enabled the hospital to forecast and plan device maintenance more efficiently.
For safety, hospitals commonly manage and store medical devices in centralized clinical engineering rooms, but this requires nurses to spend time retrieving and returning items from the centralized location. Decentralized storage can reduce this workload but make it difficult to centrally monitor how devices are being used. Both management methods can lead to deflection of stocks in wards and surplus stocking.
Recopick incorporates Teijin’s CELL FORM RFID-enabled sheets, which work like reader antennas for tracking RFID devices placed on the sheets. The sheets are produced with specialized materials and manufacturing know-how developed by Teijin. Electromagnetic waves are confined to the cell within and around each thin, flat sheet. Collected data is communicated via the @CELL system developed by CELLCROSS Co., Ltd., a venture company spun off from the University of Tokyo.
Recopick propagates ultra-high frequency (UHF) radio waves on two-dimensional surfaces, such as shelves, with minimum effect on other devices nearby. Teijin introduced Recopick in 2011 for applications that can gather real-time information, such as presence and location, on thousands of items.
Teijin is now refining Recopick for large hospitals. In addition, the company is developing applications for the Internet of Things (IoT), leveraging the system’s surface-based propagation of radio waves via CELL FORM and other solutions that use wireless LAN or PaperBeacon, the world’s first surface-based authentication beacon. Teijin is targeting sales revenue of more than JPY two billion by 2020 from IoT solutions that propagate surface radio waves, including Recopick, CELL FORM and PaperBeacon.
Recopick, CELL FORM and PaperBeacon are registered trademarks in Japan.
About the Teijin Group
Teijin (TSE: 3401) is a technology-driven global group offering advanced solutions in the areas of environmental value; safety, security and disaster mitigation; and demographic change and increased health consciousness. Its main fields of operation are high-performance fibers such as aramid, carbon fibers & composites, healthcare, films, resin & plastic processing, polyester fibers, products converting and IT. The group has some 170 companies and around 19,000 employees spread out over 20 countries worldwide. It posted consolidated sales of JPY 741.3 billion (USD 6.5 billion) and total assets of JPY 964.1 billion (USD 8.5 billion) in the fiscal year ending March 31, 2017.
+81 3 3506 4055
Information in the press releases is current on the date of the announcement.
It is subject to change without prior notice.